CC
NUVB.WS

Clearline Capital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Clearline Capital’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33,271
Closed -$3.33K – 116
2023
Q3 		$3.33K Hold
33,271
– – ﹤0.01% 125
2023
Q2 		$5.5K Hold
33,271
– – ﹤0.01% 114
2023
Q1 		$3.99K Hold
33,271
– – ﹤0.01% 108
2022
Q4 		$4.81K Hold
33,271
– – ﹤0.01% 120
2022
Q3 		$7K Hold
33,271
– – ﹤0.01% 139
2022
Q2 		$9K Hold
33,271
– – ﹤0.01% 138
2022
Q1 		$27K Buy
+33,271
New +$33.5K ﹤0.01% 130
2021
Q4 		– Sell
-33,271
Closed -$85K – 169
2021
Q3 		$85K Buy
+33,271
New +$77.9K 0.01% 152

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Clearline Capital's NUVB.WS Position: Q4 2023 in Review

Clearline Capital sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q4 2023, closing a stake of 33,271 shares — an estimated $3.33K sold.

Clearline Capital first reported a position in NUVB.WS in Q3 2021 and held it in 8 quarters. The position peaked at $85K in Q3 2021. 17 funds tracked by Wall St. Rank hold NUVB.WS as of Q4 2023.

  • Clearline Capital reported no remaining Nuvation Bio Inc Warrants position as of Q4 2023 after selling out during the quarter.
  • Clearline Capital sold 33,271 Nuvation Bio Inc Warrants shares in Q4 2023, an estimated $3.33K.
  • Clearline Capital first reported a position in Nuvation Bio Inc Warrants in Q3 2021 and held it in 8 quarters.
  • Clearline Capital's Nuvation Bio Inc Warrants position peaked at $85K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q4 2023.

Based on Clearline Capital's 13F filing for Q4 2023, filed 14 Feb 2024.